𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

✍ Scribed by Pedersen, Jannie; Carlsen, Thomas H.R.; Prentoe, Jannick; Ramirez, Santseharay; Jensen, Tanja B.; Forns, Xavier; Alter, Harvey; Foung, Steven K.H.; Law, Mansun; Gottwein, Judith; Weis, Nina; Bukh, Jens

Book ID
121862639
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
800 KB
Volume
58
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Human monoclonal antibodies that react w
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity
✍ Darren J. Schofield; Birke Bartosch; Yohko K. Shimizu; Tobias Allander; Harvey J πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 187 KB

Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di

Characterization of the hepatitis C viru
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
✍ Alexander W. Tarr; Ania M. Owsianka; Judith M. Timms; C. Patrick McClure; Richar πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 680 KB

The mouse monoclonal antibody (MAb) AP33, recognizing a 12 amino acid linear epitope in the hepatitis C virus (HCV) E2 glycoprotein, potently neutralizes retroviral pseudoparticles (HCVpp) carrying genetically diverse HCV envelope glycoproteins. Consequently, this antibody and its epitope are highly